Aikium Inc.

📍 Berkeley, United States🗓 Founded 2022👥 8 employees💰 Last funded Dec 2025
Biotechnology Research🌐 aikium.com
Website LinkedIn
Aikium is revolutionizing therapeutics with Yotta-ML², the world’s first AI-driven trillion-protein screening platform. By unlocking undruggable targets where antibodies and small molecules fail, Aikium pioneers next-generation protein therapeutics for cancer, immune disorders, and beyond—pushing the boundaries of AI-powered drug discovery.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2023–2025 · investors recorded per year
202312024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aikium Inc.?
Aikium Inc. has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Aikium Inc. last raise funding?
The most recent investment in Aikium Inc. recorded on gritt.io was in December 2025.
When was Aikium Inc. founded?
Aikium Inc. was founded in 2022.
What industry is Aikium Inc. in?
Aikium Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aikium Inc. based?
Aikium Inc. is headquartered in Berkeley, United States.